Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22429
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDimakou, K.en
dc.contributor.authorPapaioannides, D.en
dc.contributor.authorLatsi, P.en
dc.contributor.authorKatsimboula, S.en
dc.contributor.authorKorantzopoulos, P.en
dc.contributor.authorOrphanidou, D.en
dc.date.accessioned2015-11-24T19:24:10Z-
dc.date.available2015-11-24T19:24:10Z-
dc.identifier.issn1368-5031-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22429-
dc.rightsDefault Licence-
dc.subjectAntibodies, Monoclonal/*contraindicationsen
dc.subjectAntirheumatic Agents/*contraindicationsen
dc.subjectArthritis, Rheumatoid/*drug therapyen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMiddle Ageden
dc.subjectOpportunistic Infections/*complications/radiographyen
dc.subjectTomography, X-Ray Computeden
dc.subjectTuberculosis, Miliary/*complications/radiographyen
dc.subjectTuberculosis, Pulmonary/*complications/radiographyen
dc.subjectTumor Necrosis Factor-alpha/*antagonists & inhibitorsen
dc.titleDisseminated tuberculosis complicating anti-TNF-alpha treatmenten
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/15605672-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1111/j.1742-1241.2004.00061.x/asset/j.1742-1241.2004.00061.x.pdf?v=1&t=h0tb1za2&s=12ab879686078b53f30e77d372e001c007846ee6-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2004-
heal.abstractAn unusually large number of cases of tuberculosis, often of miliary or disseminated form, have been reported in patients receiving infliximab therapy for rheumatoid arthritis or Crohn's disease. We describe a patient with rheumatoid arthritis who was treated with infliximab and became systemically ill with Mycobacterium tuberculosis-disseminated infection. Patients who are candidates for treatment with tumour necrosis factor-alfa inhibitors should be evaluated for the presence of latent or activeen
heal.journalNameInt J Clin Practen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Dimakou-2004-Disseminated tubercu.pdf203.23 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons